Authors

Empowering Patients as Partners: The Next Frontier for Pharma Companies

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

A 'Beautiful Fake': Pharma Fraudsters Upping Their Game

Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global trade gaps—making detection harder and patient risk greater than ever.

AI’s Next Step in Pharma Quality: From Detection to Closed-Loop Prevention

In the final part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, explains that as pharma quality systems evolve, AI is shifting from reactive problem-solving to proactive, closed-loop risk prevention, enhancing operator insight, decision-making, and continuous process improvement.

Revolutionizing Pharma Patient Assistance Programs, KnippeRx Leads the Future of Patient Care

How the Rise in Self-Injectables Is Impacting Pharmaceutical Manufacturing

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

Why well-organized documentation is critical at every stage of the process.

Addressing the Threat of Prescription Abandonment

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?

AI-Driven Planning Poised to Transform US Healthcare Supply Chain Resilience

In the final part of her Pharma Commerce video interview, Christy Christian, senior industry principal with Kinaxis, highlights a future where AI, cleaner data, and exception-based decision-making accelerate response times and strengthen end-to-end supply chain visibility.

AI Is Redefining Pharma Forecasting, and Eliminating the Old Speed-Versus-Compliance Trade-Off

Christy Christian, senior industry principal with Kinaxis, and Hari Kiran Chereddi, CEO of HRV Pharma, explain why AI’s reliability depends on product stability, how human judgment still matters, and how a digital, AI-validated manufacturing backbone is accelerating regulatory reviews, strengthening supplier management, and transforming global production readiness.

From Uncertainty to Opportunity: Navigating IPAY 2028

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care

De-Risking Clinical Development: Strategic Multipliers in Global Trials

How Biopharma Companies Can Optimize Field Reimbursement Models

In the final part of her Pharma Commerce video interview, Megan Wetzel, VP, product, access & affordability at CoverMyMeds, shares how the right field reimbursement model structure ensures field teams have the insights and tools they need to overcome coverage barriers and accelerate patient access to therapy.

Trade & Channel Strategies 2025: Inside the Push to Optimize GTN

A session explores how manufacturers can refine GTN strategy, strengthen pricing governance, and navigate increasingly complex distribution-channel economics, while maintaining both commercial performance and patient affordability.

A Practitioner’s Guide to AI Lifecycle Management in Life Sciences

This guide outlines a proven framework, spanning process, people, and platform, to help healthcare innovators scale AI with compliance, collaboration, and clinical impact in mind.

Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation Expertise

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Finding the Human Touch in a Wired World

In the final part of her Pharma Commerce video interview, Jen Butler, CCO at Pleio, emphasizes that as digital tools become central to patient support, there is value to balancing technology with empathy.

Greener, Smarter, and Less Expensive: How Pharma Packaging is Evolving

As the sentiment of surveyed dangerous goods experts backs up, updated packaging pursuits can boost efficiency and cut costs—while mitigating the environmental impact.

Measuring What Matters

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.

From Aisles to Access: How Grocery-Based Pharmacies are Evolving into Community Health Hubs

Amid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.

How Healthcare Organizations Can Balance Federal and State AI Regulations

In the third part of her Pharma Commerce video interview, Linda Malek, JD, partner at Crowell & Moring, explains how healthcare organizations can harmonize both approaches by prioritizing fairness, transparency, and adaptable systems.

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

Pharma’s push into direct-to-patient sales is reshaping the front end of drug distribution, but wholesalers like Cencora, McKesson, and Cardinal Health remain indispensable as the backbone of the industry’s regulated, specialty, and logistics infrastructure.

Reducing Risk in the Pharmaceutical Cold Chain

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control

At LogiPharma USA, industry leaders from Tive, McKesson, and the broader healthcare logistics community discussed the sector’s transition from passive monitoring to real-time control, the growing influence of advanced therapies, and the importance of diversity and innovation in shaping the future of pharma supply chains.

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

It’s not marketing—it's the activation layer for every dollar spent on patient access and support.

Your Trusted Resource for Mission Critical Solutions

There’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.

A Practitioner’s Guide to AI Lifecycle Management in Life Sciences

This guide outlines a proven framework, spanning process, people, and platform, to help healthcare innovators scale AI with compliance, collaboration, and clinical impact in mind.